Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text

Life Sciences, Hematology, Immunology +17

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Annalisa D’Andrea, Manthrasalam Rengaraju, Nicholas M. Valiante et al. · The Journal of Experimental Medicine · 1992 · 1.2K citations · Full text

Life Sciences, Cell Biology, Immunology +10

Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

George W. Sledge, Donna Neuberg, Patricia Bernardo et al. · Journal of Clinical Oncology · 2003 · 707 citations

Medicine, Oncology, Pharmacology +15

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

Rita Golfieri, Emanuela Giampalma, Matteo Renzulli et al. · British Journal of Cancer · 2014 · 604 citations · Full text

Medicine, Oncology, Surgery +12

Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model

Huan Meng, Min Xue, Tian Xia et al. · ACS Nano · 2011 · 502 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17